Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis.

Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis.

BACKGROUND: While Resin-iferatoxin (RTX) has been widely used for patients with storage lower urinary tract symptoms (LUTS), its clinical efficiency hasn't yet been well evaluated. A meta-analysis was performed to evaluate the exact roles of intravesical RTX for the treatment of storage LUTS in...

Full description

Bibliographic Details
Main Authors:	Changcheng Guo, Bin Yang, Wenyu Gu, Bo Peng, Shengqiang Xia, Fengqiang Yang, Deyi Wen, Jiang Geng, Yuanyuan Zhang, Junhua Zheng
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3869704?pdf=render

Similar Items

Management of Neurogenic Detrusor Overactivity Caused by Spinal Cord Injury - The Case of Botulinum Toxin and Resiniferatoxin
by: Raquel Leal Monteiro Mano de Oliveira
Published: (2020)

Resiniferatoxin for detrusor instability refractory to anticholinergics
by: Paulo C.R. Palma, et al.
Published: (2004-02-01)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
by: Jing-Liang Chen, et al.
Published: (2020-02-01)

Effects of Combination Treatment of Intravesical Resiniferatoxin Instillation and Hydrodistention in Patients with Refractory Painful Bladder Syndrome/Interstitial Cystitis: A Pilot Study
by: Byeong Kuk Ham, et al.
Published: (2012-03-01)

Interstitial cystitis - intravesical treatment
by: Fernando Gonçalves de Almeida, et al.
Published: (2019-05-01)

The coexistence of interstitial cystitis and overactive bladder in a patient with lower urinary tract symptoms
by: Ching-Pei Tsai, et al.
Published: (2014-06-01)

Role of liposome in treatment of overactive bladder and interstitial cystitis
by: Shih-Ya Hung, et al.
Published: (2015-03-01)

Intravesical electromotive botulinum toxin-A administration: Will it be the standard treatment for refractory neurogenic detrusor overactivity?
by: Neeraj Kumar Goyal, et al.
Published: (2011-01-01)

Intravesical Bacillus Calmette-Guerin for Treatment of Refractory Interstitial Cystitis
by: Saeed Arasteh, et al.
Published: (2007-02-01)

In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
by: Banakhar M, et al.
Published: (2021-09-01)

Potential urinary biomarkers to diagnosis interstitial cystitis and overactive bladder
by: Y-H. Jiang, et al.
Published: (2020-07-01)

Dissimilar Effects of Tolterodine on Detrusor Overactivity in Awake Rats with Chemical Cystitis and Partial Bladder Outlet Obstruction
by: Long-Hu Jin, et al.
Published: (2011-09-01)

Development and Changes with Age of Detrusor Overactivity in Spontaneous Hypertensive Rats as Observed by Simultaneous Registrations of Intravesical and Intraabdominal Pressures
by: Long-Hu Jin, et al.
Published: (2011-12-01)

Adverse Events of Intravesical Onabotulinum Toxin A Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
by: Yuh-Chen Kuo, et al.
Published: (2016-03-01)

Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome
by: Luke Grundy, et al.
Published: (2018-12-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

Novel pharmacological treatments for detrusor overactivity
by: Biers, Suzanne Maryam
Published: (2005)

Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model
by: Ilker Fatih Sahiner, et al.

Time-Related Changes in Detrusor Overactivity in Awake Rats with Spinal Cord Injury Observed by Simultaneous Registrations of Intravesical and Intraabdominal Pressures
by: Long-Hu Jin, et al.
Published: (2011-03-01)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
by: Stacey Tannenbaum, et al.
Published: (2020-12-01)

Comparison of urodynamic results and quality of life between women with interstitial cystitis and overactive bladder
by: Chin-Chieh Hsu, et al.
Published: (2020-01-01)

Intravesical Treatments and Predictors of Symptom Severity in Patients with Refractory Interstitial Cystitis/Painful Bladder Syndrome
by: Chung-Hsin Peng, et al.
Published: (2010)

Molecular mechanisms involved in neurogenic detrusor overactivity
by: João Paulo Garrido Vieira dos Santos
Published: (2019)

Alterations of the Myovesical Plexus of the Human Overactive Detrusor
by: Kamiel A. J. Kuijpers, et al.
Published: (2014-01-01)

Assessment of lower urinary tract function in women with urodynamic stress incontinence with and without detrusor overactivity
by: Rahmanou, Philip
Published: (2012)

Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis or painful bladder syndrome
by: Wei-Ching Lee, et al.
Published: (2011-10-01)

Predicting Refractory Detrusor Overactivity: Are There any Clues at Diagnosis
by: Kylie J Mansfield, et al.
Published: (2013-12-01)

Pretreatment Features to Influence Effectiveness of Intravesical Hyaluronic Acid Instillation in Refractory Interstitial Cystitis/Painful Bladder Syndrome
by: Aram Kim, et al.
Published: (2014-09-01)

Increased detrusor collagen is associated with detrusor overactivity and decreased bladder compliance in men with benign prostatic obstruction
by: Carlos H.S. Bellucci, et al.
Published: (2017-06-01)

Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome.
by: Miguel Silva-Ramos, et al.
Published: (2013-01-01)

The Botulinum Treatment of Neurogenic Detrusor Overactivity: The Double-Face of the Neurotoxin
by: Chiara Traini, et al.
Published: (2019-10-01)

Effect of Memantine on Overactive Detrusor in Rats With Spinal Cord Injury
by: Cüneyd Özkürkçügil, et al.
Published: (2010-05-01)

Detrusor overactivity in diabetic and non-diabetic patients: is there a difference?
by: Tomasz Golabek, et al.
Published: (2012-10-01)

Clinical Outcome in Male Patients With Detrusor Overactivity With Impaired Contractility
by: Shuo Liu, et al.
Published: (2014-09-01)

Flowmetry/pelvic floor electromyographic findings in patients with detrusor overactivity
by: Farshid Alizadeh, et al.
Published: (2015-06-01)

The role of endocannabinoids and their receptors on the regulation of bladder function and detrusor overactivity
by: Bakali, Evangelia
Published: (2015)

Accuracy of bladder ultrasound in the diagnosis of detrusor overactivity (BUS study)
by: Rachaneni, Suneetha
Published: (2016)

The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome
by: Yu-Chen Peng, et al.
Published: (2020-11-01)

Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective study
by: Claudio Giberti, et al.
Published: (2013-08-01)

Cannot write session to /tmp/vufind_sessions/sess_76508bfp3t9k4tfv31dqi9mmop